You are here

Intratympanic Drug Delivery Device

Award Information
Agency: Department of Defense
Branch: Defense Health Program
Contract: W81XWH19C0041
Agency Tracking Number: H2-0409
Amount: $974,973.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: DHA172-013
Solicitation Number: 2017.3
Solicitation Year: 2017
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-02-19
Award End Date (Contract End Date): 2021-07-18
Small Business Information
DUNS: 796010411
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Sarena Horava
 (978) 856-4204
Business Contact
 Collette Jolliffe
Phone: (978) 856-4158
Research Institution
Inner ear disorders, such as hearing loss and tinnitus, are significant public health issues in the United States and worldwide, with a considerably higher prevalence among military personnel. Such inner ear disorders, particularly when associated with acute noise or blast exposure in military personnel, require timely intervention. However, local drug delivery to treat the inner ear disorders requires clinical expertise and specialized instrumentation. Military personnel have limited access to such specialized medical care while deployed in remote settings, where many of these noise-related injuries are sustained. Triton Systems proposes to further develop and test an intratympanic drug delivery device for minimally invasive treatments of inner ear disorders. Our system will enable intratympanic administration of time-critical therapies in a safe and effective manner, even in remote settings.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government